ABH Healthcare IPO GMP, Date, Price Band & Review

ABH Healthcare IPO Details

ABH Healthcare IPO is a 100% book-built issue of ₹35 crore, entirely a fresh issue with a face value of ₹10 per share, of which ₹2 crore is reserved for market makers. The company filed its DRHP with SEBI on June 27, 2025. The company filed its DRHP with SEBI on June 27, 2025.

The price band of the issue is set between ₹96 and ₹102 per share and the lot size for an application is 1,200 shares. The minimum amount of investment required by an individual investor (retail) is ₹2,44,800 (2,400 shares). The IPO will open for subscription from August 24 to 26, 2026, on the NSE SME platform, with a tentative listing date fixed as August 31, 2026. The book-running lead manager of the issue is Fedex Securities Private Limited, while the registrar to the issue is Bigshare Services Private Limited.

ABH Healthcare IPO Date & Timeline

The ABH Healthcare IPO is officially set to open for subscription on Aug 24, 2026 and will close on Aug 26, 2026. The company initially filed its Draft Red Herring Prospectus (DRHP) on June 27, 2025 and has now finalized its schedule following SEBI approval. Once the subscription window closes, allotment is expected on Aug 27, 2026. Following this, the firm will initiate refunds and credit shares to successful investors' demat accounts on Aug 28, 2026. Finally, shares of ABH Healthcare Ltd. are tentatively scheduled to list on the stock exchanges on Aug 31, 2026.

ABH Healthcare IPO GMP (Grey Market Premium)

“Grey Market Premium” or GMP is defined as the rate at which the IPO's shares are traded in the market before they are officially listed on the stock exchange.

The ABH Healthcare IPO GMP is currently trading at ₹0, reflecting the sentiment of unofficial investors before the official listing. This premium suggests a potential listing price of ₹102, which is 0.00% above the issue price. While the Grey Market Premium is a key indicator of demand and investor appetite, it is important to remember that GMP is highly volatile and should not be the sole factor in your investment decisions.

Company Background

Established in 1985 with a 30-bed setup, Anil Baghi Hospital has grown over four decades into a well-known healthcare institution in Punjab. Later, in 2022, this proprietorship of Dr. Kamal Baghi was acquired by ABH Healthcare Ltd., which was incorporated in 2021, with the main aim of providing high-quality medical services at an affordable level.

This hospital has evolved from a small clinic into a NABH-accredited super-speciality hospital serving a wide regional patient base. Providing specialised tertiary medical care in Tier 3 cities, operating under the brand name of “Anil Baghi Hospital” to honour the sacrifice of the late Shri Anil Baghi. ABH Healthcare has already successfully treated 4,000 patients with 70+ different types of procedures.

Currently, the company was preparing for a public listing to expand and fund its inorganic growth through unidentified acquisitions and to maintain its daily operational activities.

Operations & Product Range

ABH Healthcare Ltd. follows a multi-speciality model, offering treatment across 25 medical specialities, including key areas like cardiac sciences, neurology, neurosurgery, orthopaedics, joint replacement and urology. Also, it provides services in laparoscopic surgery, gastroenterology and nephrology, along with essential support services such as radiology, physiotherapy and drug de-addiction programs. The hospital mainly serves patients from Ferozepur, Punjab, including both self-paying individuals and those covered under insurance and government schemes.

Facilities & Capacity

ABH Healthcare Ltd. has steadily expanded its infrastructure to meet growing demand, increasing from 100 beds in FY24 to 150 beds by FY26. Also, the company has managed 125 beds for operations and a 70-bed ICU setup by FY26. The facility is equipped with advanced technology such as cardiac catheterisation labs and modern diagnostic imaging equipment, mainly to provide specialised tertiary medical care in Tier 3 cities within the state of Punjab, maintaining a balance between high-quality medical services and affordable treatment.

Brands & Market Presence

ABH Healthcare Ltd. operates under the well-known brand name "Anil Baghi Hospital," which has built strong clinical trust over 40 years, starting with 30 beds and now reaching 150 beds and about 125 operational beds. It is NABH-accredited, reflecting high standards of quality and safety and also holds NABH Digital Standards accreditation, showing its focus on technology in patient care. Its presence is further strengthened through empanelment with key government schemes like Ayushman Bharat (AB-PMJAY), CGHS and ECHS.

Revenue Streams & Business Model

ABH Healthcare Ltd. operates a doctor-led, 150-bed multispecialty tertiary hospital under the brand "Anil Baghi Hospital" in Ferozepur, Punjab. The firm generates revenue across 25 medical specialities through outpatient consultations, inpatient care, diagnostic services and surgical procedures. The business model combines cash-paying patients, private insurance providers, third-party administrators and government healthcare panel schemes like Ayushman Bharat to maintain a diversified patient base.

Financial Performance

ABH Healthcare Ltd. shows top-line growth and stable operational expansion across recent fiscal years. Revenue from operations rose from ₹41.38 crore in FY24 to ₹51.04 crore in FY26. Profit after tax surged from ₹1.66 crore in FY24 to ₹5.69 crore in FY26. This margin expansion brought EBITDA to ₹14.44 crore in FY26, pushing return on equity to 39.46% while supporting total net worth expansion to ₹17.27 crore.

Management & Shareholding

The promoters of ABH Healthcare Ltd. are Dr. Kamal Baghi, Dr. Saurabh Baghi and Dr. Vaishali Saini, who bring extensive medical and administrative experience. Dr. Kamal Baghi, with over 40 years of experience, serves as Chairman and Whole-time Director. Before the IPO, the promoters held 100% of the equity, with Dr. Saurabh Baghi owning 68.50% and Dr. Kamal Baghi holding 30.00%. After the IPO, their combined stake will reduce due to fresh equity issuance, but they will continue to retain significant control over the company’s direction.

Board & Key Management

The leadership of ABH Healthcare Ltd. is led by a team of experts with many years of experience. Dr. Kamal Baghi serves as the Chairman & Whole-time Director and gives strategic direction to the firm and manages the daily operations along with Dr. Saurabh Baghi, the Managing Director. To ensure good governance, the board includes Independent Directors Dr. Satnam Singh Nijjar and Mr. Balwinder Singh for honest oversight. Together, this team uses its knowledge to help the company grow and stay successful.